Putting East London at the forefront of healthcare innovations
Clinical trials strengthen the future of healthcare. They are vitally important in the development of new treatments, medications or devices, by ensuring they are safe and effective in people.
Diversity in trials means treatments can be more effective, and more suitable, for communities such as those in East London, which can in turn contribute to higher life expectancy and better health outcomes.
To address this, we are building a new Clinical Research Facility in Whitechapel. This world-class facility will enable research teams to develop innovative new therapies, putting East London at the forefront of cutting-edge healthcare innovations.
The new centre will significantly expand local clinical participation in trials and will make sure people in East London benefit from the results of clinical studies. Clinical trials in this area will not only make better, more tailored treatments for the local population, but for millions of underrepresented people around the world.
With your support, we can build this critically-needed centre and develop the life-saving treatments of tomorrow.
Clinical research: a patient’s perspective
A new Clinical Research Facility: our vision
- Our local populations will be better represented in important trials, including those living with long-term conditions like diabetes, kidney, heart and liver disease, and rheumatoid arthritis – with the goal of developing tailored and relevant interventions.
- Patients will benefit from the new Facility, since those taking part in clinical trials generally have better experiences and outcomes than those who receive standard care packages. It will also bring greater benefit to the wider population through the earlier translation of research into clinical practice.
- Vastly improved trial facilities with large laboratories and room for patients to stay overnight will enable the hospital to be part of a wider range of studies including early phase trials, novel therapies, remote monitoring, genetics and medical devices.
- The world’s best scientists will be attracted to East London by offering world-class facilities that attract world-class trials. This will bring enhanced reputation and recruitment opportunities for our partners at Barts Health and Queen Mary University of London.
Maximising research opportunities
By creating world-class facilities we will attract world-class trials that will in turn help recruit and retain the world’s best research teams.
These three pillars of excellence will be self-sustaining, since the best research teams will also reinforce the appeal to partners looking for somewhere to conduct their trials.
This model will help transform The Royal London’s Clinical Research Facility from a nationally admired Centre to a globally significant research institution that shapes the future of healthcare through truly world-class innovations.
The project recently received the endorsement of a £1 million National Institute of Health and Care Research (NIHR) Clinical Research Facility infrastructure award, allowing us to join the national NIHR CRF network.